What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Gene
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin resistance, Insulin and Diabetes mellitus.
His Internal medicine study combines topics in areas such as Gastroenterology and Type 2 diabetes.
His is doing research in Adiponectin, Insulin receptor, IRS2, Leptin and Adipose tissue, both of which are found in Endocrinology.
The various areas that Yasuo Terauchi examines in his Adiponectin study include Metabolic syndrome and Adipokine.
His Glucose tolerance test study in the realm of Insulin resistance interacts with subjects such as Epigenetics of diabetes Type 2.
His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Hematocrit, Vascular permeability, Edema and Urology.
His most cited work include:
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (4196 citations)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (2607 citations)
- Disruption of adiponectin causes insulin resistance and neointimal formation. (1221 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Type 2 Diabetes Mellitus.
Insulin receptor, IRS2, Adiponectin, Glucokinase and IRS1 are subfields of Endocrinology in which his conducts study.
His Diabetes mellitus research incorporates elements of Body mass index, Obesity and Surgery.
His work on Liraglutide as part of general Type 2 diabetes study is frequently linked to In patient, bridging the gap between disciplines.
His Insulin resistance research is multidisciplinary, relying on both Adipose tissue, Adipocyte, Metabolic syndrome and Leptin.
He most often published in these fields:
- Internal medicine (78.44%)
- Endocrinology (55.92%)
- Diabetes mellitus (37.44%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (78.44%)
- Type 2 diabetes (35.78%)
- Diabetes mellitus (37.44%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology and Type 2 Diabetes Mellitus.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gastroenterology.
His work on Empagliflozin is typically connected to In patient as part of general Type 2 diabetes study, connecting several disciplines of science.
The study incorporates disciplines such as Body mass index, Adverse effect and Confidence interval in addition to Diabetes mellitus.
His Endocrinology study typically links adjacent topics like Fatty liver.
His Type 2 Diabetes Mellitus research integrates issues from Postmarketing surveillance, Glucagon-like peptide 1 receptor, Pediatrics and Family medicine.
Between 2018 and 2021, his most popular works were:
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes (72 citations)
- Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study) (11 citations)
- Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus. (10 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
Diabetes mellitus, Internal medicine, Type 2 diabetes, Endocrinology and Glycemic are his primary areas of study.
He has included themes like Adverse effect and Quality of life in his Diabetes mellitus study.
His Internal medicine research includes elements of Gastroenterology and Dapagliflozin.
His work on Canagliflozin as part of general Type 2 diabetes study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His research on Endocrinology frequently links to adjacent areas such as Downregulation and upregulation.
His work deals with themes such as Dietary carbohydrate, Carbohydrate, Dietary history and Physiology, which intersect with Glycemic.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
